A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells In Vivo

Chimeric antigen receptor (CAR) T cells have proven to be a powerful cellular therapy for B cell malignancies. Massive efforts are now being undertaken to reproduce the high efficacy of CAR T cells in the treatment of other malignancies. Here, predictive preclinical model systems are important, and...

Full description

Bibliographic Details
Main Authors: Susana Pascoal, Benjamin Salzer, Eva Scheuringer, Andrea Wenninger-Weinzierl, Caterina Sturtzel, Wolfgang Holter, Sabine Taschner-Mandl, Manfred Lehner, Martin Distel
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/3/567
_version_ 1797766488392728576
author Susana Pascoal
Benjamin Salzer
Eva Scheuringer
Andrea Wenninger-Weinzierl
Caterina Sturtzel
Wolfgang Holter
Sabine Taschner-Mandl
Manfred Lehner
Martin Distel
author_facet Susana Pascoal
Benjamin Salzer
Eva Scheuringer
Andrea Wenninger-Weinzierl
Caterina Sturtzel
Wolfgang Holter
Sabine Taschner-Mandl
Manfred Lehner
Martin Distel
author_sort Susana Pascoal
collection DOAJ
description Chimeric antigen receptor (CAR) T cells have proven to be a powerful cellular therapy for B cell malignancies. Massive efforts are now being undertaken to reproduce the high efficacy of CAR T cells in the treatment of other malignancies. Here, predictive preclinical model systems are important, and the current gold standard for preclinical evaluation of CAR T cells are mouse xenografts. However, mouse xenograft assays are expensive and slow. Therefore, an additional vertebrate in vivo assay would be beneficial to bridge the gap from in vitro to mouse xenografts. Here, we present a novel assay based on embryonic zebrafish xenografts to investigate CAR T cell-mediated killing of human cancer cells. Using a CD19-specific CAR and Nalm-6 leukemia cells, we show that live observation of killing of Nalm-6 cells by CAR T cells is possible in zebrafish embryos. Furthermore, we applied Fiji macros enabling automated quantification of Nalm-6 cells and CAR T cells over time. In conclusion, we provide a proof-of-principle study that embryonic zebrafish xenografts can be used to investigate CAR T cell-mediated killing of tumor cells. This assay is cost-effective, fast, and offers live imaging possibilities to directly investigate CAR T cell migration, engagement, and killing of effector cells.
first_indexed 2024-03-12T20:26:01Z
format Article
id doaj.art-0895cd8a570f4031ac1fafd02ede7b64
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T20:26:01Z
publishDate 2020-02-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-0895cd8a570f4031ac1fafd02ede7b642023-08-02T00:29:26ZengMDPI AGCancers2072-66942020-02-0112356710.3390/cancers12030567cancers12030567A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells In VivoSusana Pascoal0Benjamin Salzer1Eva Scheuringer2Andrea Wenninger-Weinzierl3Caterina Sturtzel4Wolfgang Holter5Sabine Taschner-Mandl6Manfred Lehner7Martin Distel8Innovative Cancer Models, St. Anna Children’s Cancer Research Institute, Zimmermannplatz 10, 1090 Vienna, AustriaChristian Doppler Laboratory for Next Generation CAR T Cells, Zimmermannplatz 10, 1090 Vienna, AustriaInnovative Cancer Models, St. Anna Children’s Cancer Research Institute, Zimmermannplatz 10, 1090 Vienna, AustriaInnovative Cancer Models, St. Anna Children’s Cancer Research Institute, Zimmermannplatz 10, 1090 Vienna, AustriaInnovative Cancer Models, St. Anna Children’s Cancer Research Institute, Zimmermannplatz 10, 1090 Vienna, AustriaDevelopment of Cellular Therapeutics, St. Anna Children’s Cancer Research Institute, Zimmermannplatz 10, 1090 Vienna, AustriaTumor Biology, St. Anna Children’s Cancer Research Institute, Zimmermannplatz 10, 1090 Vienna, AustriaChristian Doppler Laboratory for Next Generation CAR T Cells, Zimmermannplatz 10, 1090 Vienna, AustriaInnovative Cancer Models, St. Anna Children’s Cancer Research Institute, Zimmermannplatz 10, 1090 Vienna, AustriaChimeric antigen receptor (CAR) T cells have proven to be a powerful cellular therapy for B cell malignancies. Massive efforts are now being undertaken to reproduce the high efficacy of CAR T cells in the treatment of other malignancies. Here, predictive preclinical model systems are important, and the current gold standard for preclinical evaluation of CAR T cells are mouse xenografts. However, mouse xenograft assays are expensive and slow. Therefore, an additional vertebrate in vivo assay would be beneficial to bridge the gap from in vitro to mouse xenografts. Here, we present a novel assay based on embryonic zebrafish xenografts to investigate CAR T cell-mediated killing of human cancer cells. Using a CD19-specific CAR and Nalm-6 leukemia cells, we show that live observation of killing of Nalm-6 cells by CAR T cells is possible in zebrafish embryos. Furthermore, we applied Fiji macros enabling automated quantification of Nalm-6 cells and CAR T cells over time. In conclusion, we provide a proof-of-principle study that embryonic zebrafish xenografts can be used to investigate CAR T cell-mediated killing of tumor cells. This assay is cost-effective, fast, and offers live imaging possibilities to directly investigate CAR T cell migration, engagement, and killing of effector cells.https://www.mdpi.com/2072-6694/12/3/567zebrafish xenograftscar t cellscd19 carin vivo imaging
spellingShingle Susana Pascoal
Benjamin Salzer
Eva Scheuringer
Andrea Wenninger-Weinzierl
Caterina Sturtzel
Wolfgang Holter
Sabine Taschner-Mandl
Manfred Lehner
Martin Distel
A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells In Vivo
Cancers
zebrafish xenografts
car t cells
cd19 car
in vivo imaging
title A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells In Vivo
title_full A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells In Vivo
title_fullStr A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells In Vivo
title_full_unstemmed A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells In Vivo
title_short A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells In Vivo
title_sort preclinical embryonic zebrafish xenograft model to investigate car t cells in vivo
topic zebrafish xenografts
car t cells
cd19 car
in vivo imaging
url https://www.mdpi.com/2072-6694/12/3/567
work_keys_str_mv AT susanapascoal apreclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo
AT benjaminsalzer apreclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo
AT evascheuringer apreclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo
AT andreawenningerweinzierl apreclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo
AT caterinasturtzel apreclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo
AT wolfgangholter apreclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo
AT sabinetaschnermandl apreclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo
AT manfredlehner apreclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo
AT martindistel apreclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo
AT susanapascoal preclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo
AT benjaminsalzer preclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo
AT evascheuringer preclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo
AT andreawenningerweinzierl preclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo
AT caterinasturtzel preclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo
AT wolfgangholter preclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo
AT sabinetaschnermandl preclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo
AT manfredlehner preclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo
AT martindistel preclinicalembryoniczebrafishxenograftmodeltoinvestigatecartcellsinvivo